Publication Database

The publication database contains all articles from HZI staff (formerly Gesellschaft für Biotechnologische Forschung (GBF)) since 2000.

 

Cornberg,M., Lok,A.S., Terrault,N.A., Zoulim,F. (2020)
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
J.Hepatol. 72 (3)
Maasoumy,B., Geretti,A.M., Frontzek,A., Austin,H., Aretzweiler,G., Garcia-Álvarez,M., Leuchter,S., Simon,C.O., Marins,E.G., Canchola,J.A., Cornberg,M., ... , Delgado,R., Wedemeyer,H. (2020)
HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination
Hepatol.Commun. 4 (7)
Yang,D., Dai,Z., Yang,T., Balakrishnan,A., Yuan,Q., Vondran,F.W.R., Manns,M.P., Ott,M., ... , Cantz,T., Sharma,A.D. (2020)
MicroRNA-125b-5p Regulates Hepatocyte Proliferation During the Termination Phase of Liver Regeneration
Hepatol.Commun. 4 (12)
Sara,A.A., Um-E-Farwa,, Saeed,A., Kalesse,M. (2021)
Recent Applications of the Diels-Alder Reaction in the Synthesis of Natural Products (2017-2020)
Synthesis
Maharachchikumbura,S.S.N., Chen,Y., Ariyawansa,H.A., Hyde,K.D., Haelewaters,D., Perera,R.H., Samarakoon,M.C., Wanasinghe,D.N., Bustamante,D.E., Liu,J.K., Lawrence,D.P., ... , Cheewangkoon,R., Stadler,M. (2021)
Integrative approaches for species delimitation in Ascomycota
Fungal Diversity
Schütte,K., Schulz,C., Vilchez-Vargas,R., Vasapolli,R., Palm,F., Simon,B., Schomburg,D., Lux,A., Geffers,R., Pieper,D.H., ... , Link,A., Malfertheiner,P. (2021)
Impact of healthy aging on active bacterial assemblages throughout the gastrointestinal tract
Gut Microbes 13 (1)
Friedrich,C., Taggenbrock,R.L.R.E., Doucet-Ladeveze,R., Golda,G., Moenius,R., Arampatzi,P., Kragten,N.A.M., Kreymborg,K., Gomez de Agüero,M., Kastenmüller,W., Saliba,A.E., Grün,D., ... , van Gisbergen,K.P.J.M., Gasteiger,G. (2021)
Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues
Nat.Immunol.
Crous,P.W., Lombard,L., Sandoval-Denis,M., Seifert,K.A., Schroers,H.J., Chaverri,P., Gene,J., Guarro,J., Hirooka,Y., Bensch,K., Kema,G.H.J., Lamprecht,S.C., Cai,L., Rossman,A.Y., Stadler,M., Summerbell,R.C., Taylor,J.W., Ploch,S., Visagie,C.M., Yilmaz,N., Frisvad,J.C., Abdel-Azeem,A.M., Abdollahzadeh,J., Abdolrasouli,A., Akulov,A., Alberts,J.F., Araujo,J.P.M., Ariyawansa,H.A., Bakhshi,M., Bendiksby,M., Ben Hadj Amor,A., Bezerra,J.D.P., Boekhout,T., Camara,M.P.S., Carbia,M., Cardinali,G., Castaneda-Ruiz,R.F., Celis,A., Chaturvedi,V., Collemare,J., Croll,D., Damm,U., Decock,C.A., de Vries,R.P., Ezekiel,C.N., Fan,X.L., Fernandez,N.B., Gaya,E., Gonzalez,C.D., Gramaje,D., Groenewald,J.Z., Grube,M., Guevara-Suarez,M., Gupta,V.K., Guarnaccia,V., Haddaji,A., Hagen,F., Haelewaters,D., Hansen,K., Hashimoto,A., Hernandez-Restrepo,M., Houbraken,J., Hubka,V., Hyde,K.D., Iturriaga,T., Jeewon,R., Johnston,P.R., Jurjevic,Z, Karalti,I., Korsten,L., Kuramae,E.E., Kusan,I., Labuda,R., Lawrence,D.P., Lee,H.B., Lechat,C., Li,H.Y., Litovka,Y.A., Maharachchikumbura,S.S.N., Marin-Felix,Y., Matio Kemkuignou,B., Matocec,N., McTaggart,A.R., Mlcoch,P., Mugnai,L., Nakashima,C., Nilsson,R.H., Noumeur,S.R., Pavlov,I.N., Peralta,M.P., Phillips,A.J.L., Pitt,J.I., Polizzi,G., Quaedvlieg,W., Rajeshkumar,K.C., Restrepo,S., Rhaiem,A., Robert,J., Robert,V., Rodrigues,A.M., Salgado-Salazar,C., Samson,R.A., Santos,A.C.S., Shivas,R.G., Souza-Motta,C.M., Sun,G.Y., Swart,W.J., Szoke,S., Tan,Y.P., Taylor,J.E., Taylor,P.W.J., Tiago,P.V., Vaczy,K.Z., van de Wiele,N., van der Merwe,N.A., Verkley,G.J.M., Vieira,W.A.S., Vizzini,A., Weir,B.S., Wijayawardene,N.N., Xia,J.W., Yanez-Morales,M.J., Yurkov,A., Zamora,J.C., Zare,R., ... , Zhang,C.L., Thines,M. (2021)
Fusarium: more than a node or a foot-shaped basal cell
Stud.Mycol. 98 (April 2021)
Kuhnert,E., Navarro-Munoz,J.C., Becker,K., Stadler,M., Collemare,J., Cox,R.J. (2021)
Secondary metabolite biosynthetic diversity in the fungal family Hypoxylaceae and Xylaria hypoxylon
Stud.Mycol. 99 (June 2021)
Kazmaier,U., Junk,L. (2021)
Recent developments on the synthesis and bioactivity of ilamycins/rufomycins and cyclomarins, marine cyclopeptides that demonstrate anti-malaria and anti-tuberculosis activity
Mar.Drugs 19 (8)